Search
Qualifier English: Anti-Dyskinesia Agents
Qualifier Spanish: Antidiscinéticos
Descriptor antidiscinéticos
Entry term(s) fármacos antidiscinesia
fármacos antidiscinéticos
fármacos antidisquinesia
fármacos para desórdenes del movimiento
Scope note: Fármacos que se utilizan en el tratamiento de los trastornos del movimiento. La mayoría de ellas actúan centralmente en los sistemas dopaminérgicos o colinérgicos. Entre las más importantes desde el punto de vista clínico se encuentran las utilizadas para el tratamiento de la enfermedad de Parkinson (FÁRMACOS ANTIPARKINSONIANOS) y en las discinesias tardías.
Qualifier Portuguese: Antidiscinéticos
Qualifier French: Antidyskinésiques
Entry term(s): Agents, Anti-Dyskinesia
Agents, Movement Disorder
Anti Dyskinesia Agents
Disorder Agents, Movement
Movement Disorder Agents
Tree number(s): D27.505.954.427.090
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D018726
Scope note: Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Antiparkinson Agents (1976-1994)
Public MeSH Note: 95
History Note: 95
DeCS ID: 32365
Unique ID: D018726
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1995/01/01
Date of Entry: 1994/06/03
Revision Date: 2014/06/25
Anti-Dyskinesia Agents - Preferred
Concept UI M0028056
Scope note Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
Preferred term Anti-Dyskinesia Agents
Entry term(s) Agents, Anti-Dyskinesia
Agents, Movement Disorder
Anti Dyskinesia Agents
Disorder Agents, Movement
Movement Disorder Agents



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey